evidence: A nucleotide analogue, Remdesivir drug, is viewed as the most potential treatment for SARS-CoV-2infection. A notable study reported the improvement in patients after remdesivir therapy. Totally, 53 patients were treated with remde remdesivir. The patients were administered single dosage per day (200 mg). Among the treated, 36 reported improvement in the health condition (Grein 2020). [...] Grein J et al (2020) Compassionate use of remdesivir for patients with severe Covid-19. N Engl J Med. https://doi.org/10.1056/NEJMoa2007016